© Siemens

Siemens Healthineers recorded volume growth in most businesses; revenue in the Varian business slightly lower compared to the high comparative base in Q2 FY 2023 There was a higher result year-on-year with increases in most businesses, offset by a decline in the Imaging business due to a less favorable mix of businesses; reporting and prior year period were impacted by €0.1 billion related to the transformation of the Diagnostics business. were impacted by € 0.1 billion in connection with the transformation of the Diagnostics business; Q2 FY 2023 had included impairments and other charges totaling € 0.3 billion in connection with the realignment of certain activities in the Advanced Therapies business.